Wealthspire Advisors (Maryland)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,052
| Closed | -$82K | – | 1334 |
|
|
2019
Q1 | $82K | Buy |
1,052
+454
| +76% | +$35.4K | 0.01% | 712 |
|
|
2018
Q4 | $51K | Sell |
598
-14
| -2% | -$1.19K | ﹤0.01% | 850 |
|
|
2018
Q3 | $105K | Buy |
612
+9
| +1% | +$1.54K | 0.01% | 667 |
|
|
2018
Q2 | $78K | Buy |
603
+100
| +20% | +$12.9K | 0.01% | 805 |
|
|
2018
Q1 | $52K | Buy |
503
+88
| +21% | +$9.1K | ﹤0.01% | 964 |
|
|
2017
Q4 | $35K | Buy |
415
+98
| +31% | +$8.27K | ﹤0.01% | 1144 |
|
|
2017
Q3 | $27K | Buy |
317
+245
| +340% | +$20.9K | ﹤0.01% | 1197 |
|
|
2017
Q2 | $5K | Buy |
+72
| New | +$5K | ﹤0.01% | 1769 |
|